Does REPAGLINIDE Cause Hypoglycaemic encephalopathy? 12 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 12 reports of Hypoglycaemic encephalopathy have been filed in association with REPAGLINIDE (Repaglinide). This represents 0.5% of all adverse event reports for REPAGLINIDE.
12
Reports of Hypoglycaemic encephalopathy with REPAGLINIDE
0.5%
of all REPAGLINIDE reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hypoglycaemic encephalopathy From REPAGLINIDE?
Of the 12 reports, 5 (41.7%) required hospitalization, and 10 (83.3%) were considered life-threatening.
Is Hypoglycaemic encephalopathy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for REPAGLINIDE. However, 12 reports have been filed with the FAERS database.
What Other Side Effects Does REPAGLINIDE Cause?
Hypoglycaemia (665)
Acute kidney injury (281)
Lactic acidosis (163)
Hypoglycaemic coma (125)
Sopor (91)
Confusional state (89)
Drug interaction (89)
Blood glucose increased (88)
Diarrhoea (87)
Dyspnoea (87)
What Other Drugs Cause Hypoglycaemic encephalopathy?
METFORMIN (59)
GLIMEPIRIDE (49)
INSULIN GLARGINE (33)
INSULIN DEGLUDEC (24)
INSULIN ASPART (23)
SITAGLIPTIN (19)
INSULIN HUMAN (15)
GLYBURIDE (13)
INSULIN ASPART\INSULIN DEGLUDEC (12)
INSULIN LISPRO (9)
Which REPAGLINIDE Alternatives Have Lower Hypoglycaemic encephalopathy Risk?
REPAGLINIDE vs REPOTRECTINIB
REPAGLINIDE vs REQUIP
REPAGLINIDE vs RESLIZUMAB
REPAGLINIDE vs RESMETIROM
REPAGLINIDE vs RESTASIS